Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.55B | 9.45B | 9.49B | 10.11B | 9.39B | 7.84B |
Gross Profit | 1.73B | 1.73B | 1.65B | 1.95B | 1.94B | 1.39B |
EBITDA | 569.40M | 501.90M | 494.50M | 780.20M | 795.70M | 267.60M |
Net Income | 162.00M | 131.30M | -35.40M | 196.40M | 250.00M | -220.50M |
Balance Sheet | ||||||
Total Assets | 7.41B | 7.55B | 7.77B | 7.95B | 7.89B | 7.34B |
Cash, Cash Equivalents and Short-Term Investments | 623.20M | 793.30M | 767.70M | 644.50M | 770.70M | 1.07B |
Total Debt | 3.27B | 3.31B | 3.57B | 3.60B | 3.66B | 3.68B |
Total Liabilities | 5.63B | 5.79B | 6.10B | 6.29B | 6.44B | 6.24B |
Stockholders Equity | 1.78B | 1.75B | 1.68B | 1.66B | 1.45B | 1.09B |
Cash Flow | ||||||
Free Cash Flow | 136.00M | 167.00M | 101.20M | -1.60M | 495.70M | -79.20M |
Operating Cash Flow | 171.10M | 208.00M | 152.20M | 49.10M | 549.50M | -38.20M |
Investing Cash Flow | 112.60M | 81.20M | 48.90M | -120.70M | -749.50M | -257.80M |
Financing Cash Flow | -221.80M | -253.40M | -120.80M | -79.30M | -65.80M | 571.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $12.30B | 23.42 | 8.16% | ― | 13.63% | 78.40% | |
76 Outperform | $2.64B | 16.83 | 9.53% | ― | 1.24% | 1205.18% | |
76 Outperform | $42.48B | 43.52 | 12.15% | ― | 13.14% | 1.70% | |
67 Neutral | $1.48B | ― | -6.44% | 2.10% | 6.69% | -137.52% | |
60 Neutral | $2.31B | 31.77 | 5.32% | 0.96% | 13.87% | 90.42% | |
59 Neutral | C$1.23B | 0.83 | -8.20% | 5.16% | 9.89% | -25.14% | |
57 Neutral | $1.24B | ― | -1.09% | 1.57% | 14.79% | 82.32% |
On June 19, 2025, Brett White announced his resignation from the board of Cushman & Wakefield, effective July 31, 2025, after over a decade of service. He will transition to a strategic consultant role until February 28, 2026. White’s leadership was pivotal in the company’s growth, including its IPO and strategic investments. The board has appointed Susan Daimler, Timothy Wennes, and Stephen D. Plavin as new directors, with Plavin becoming the Chairman on October 1, 2025. These appointments align with the company’s strategic focus on growth and innovation, enhancing its capabilities in commercial real estate and technology.
The most recent analyst rating on (CWK) stock is a Hold with a $14.00 price target. To see the full list of analyst forecasts on Cushman & Wakefield stock, see the CWK Stock Forecast page.
On May 15, 2025, Cushman & Wakefield held its annual general meeting where shareholders approved several key proposals. These included the election of directors, ratification of KPMG LLP as the independent auditor, and approval of executive compensation plans. The decisions reflect the company’s ongoing governance and strategic planning efforts, impacting its operational and financial oversight.
The most recent analyst rating on (CWK) stock is a Hold with a $12.00 price target. To see the full list of analyst forecasts on Cushman & Wakefield stock, see the CWK Stock Forecast page.